Big Kahuna Small molecule preformulation

Importance of Topic

The early‐stage preformulation of small molecules is critical to pharmaceutical development. It informs solubility, polymorphism, salt and cocrystal selection, and process chemistry screening, helping to de-risk later stages of drug development and ensuring robust formulation strategies.

Objectives and Overview

This workflow guide presents the Big Kahuna automated platform designed for high‐throughput small molecule preformulation. The system aims to enable hundreds of parallel experiments with minimal material consumption, accelerating the exploration of solubility, polymorphism, salt selection, cocrystal formation, and reaction screening within a single integrated instrument.

Methodology and Instrumentation

The Big Kahuna platform integrates multiple modules on a robotic deck:

• Liquid Handling: Heated 4-tip dispenser (1 mL per tip, up to 120 °C) and viscous liquid dispenser for 10–10 000 µL.
• Solid Dispense: Classic stirrer and vibratory hopper mechanisms for 0.5 mg–100 mL powder dosing.
• Temperature Control: Three‐position heating/cooling/stirring stations (–20 °C to 180 °C, 750 rpm) and a heated filter block (ambient to 120 °C).
• Crystallization Block: 96 independent wells for parallel polymorph and solubility screening.
• Analytical Integration: On-deck pH probe (1–13 pH), vortex station, balance with camera (0.01 mg sensitivity), and optional off-deck XRD, birefringence, Raman instruments.

Main Results and Discussion

Using logical recipe–based software, up to 384 crystallization or 96 reaction screening experiments can be designed and executed in a single run. The system supports high‐throughput solubility, LogP/LogD, chiral resolution, salt/solvent screens, and cocrystal trials. Elevated temperature transfers and filtration avoid API precipitation and enable complex slurry, cooling, evaporation, and reaction protocols fully automated on one platform.

Benefits and Practical Applications

• Material Efficiency: Hundreds of experiments use minimal sample mass.
• Throughput: Parallelization reduces development timelines.
• Data Quality: Integrated analytics enable nondestructive crystal analysis by birefringence, XRD, and Raman.
• Flexibility: Configurable modules accommodate varied workflows from solubility to reaction screening.

Future Trends and Possibilities

Integration of real‐time analytics and machine learning for predictive formulation optimization, expansion to biopharmaceutical preformulation, and enhanced virtual integration with advanced third-party detectors will further accelerate early‐stage development.

Conclusion

The Big Kahuna platform offers a unified, high-throughput solution for small molecule preformulation, combining flexible module integration, advanced analytics, and recipe-driven automation to streamline drug development workflows.

Used Instrumentation

• Heated 4-tip liquid dispenser (1 mL tips, 120 °C)
• Positive displacement viscous liquid dispenser (10–10 000 µL)
• Screw-fed powder dispense hopper (0.5 mg–100 mL)
• Three‐position heating/cooling/stirring station (–20 °C to 180 °C)
• 96-well crystallization block
• Integrated balance with camera (0.01 mg sensitivity)
• On-deck pH probe (1–13 pH), vortex station, heated filter block
• Optional off-deck XRD, birefringence microscope, Raman spectrometer